Recent Advances in Pulmonary Medicine

Abstract
Traditionally a discipline based on physiology for the functional assessment of patients with lung disease, pulmonary medicine has been moving over the past decade into the realm of cellular and molecular biology in an attempt to unravel mechanisms of disease. Advances in understanding the pathogenesis of diseases such as cystic fibrosis, alpha1-antitrypsin deficiency, and asthma have resulted in changes in therapeutic strategy as well as new and promising forms of treatment. At the same time, more sophisticated imaging methods have opened up a new world of structural characterization of disease. On the other hand, the respiratory complications of . . .